市場調査レポート

商品コード

1441277

ペーパー診断の世界市場規模、シェア、成長分析、製品タイプ別、装置タイプ別-産業予測、2023～2030年

Global Paper Diagnostics Market Size, Share, Growth Analysis, By Product(Lateral Flow Assays, Dipsticks), By Device Type(Diagnostic Devices, Monitoring Devices) - Industry Forecast 2023-2030

出版日: 2024年02月18日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 822,083円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 961,682円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,101,281円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.11円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ペーパー診断の世界市場規模は2022年に83億5,000万米ドルと評価され、予測期間中（2024～2031年）のCAGRは8%で、2023年の90億2,000万米ドルから2031年には166億9,000万米ドルに成長する展望です。

ペーパー診断市場は、ポイントオブケア試験のためのポータブルでコスト効率の高い選択肢として、著しい成長を遂げています。これらの機器は紙ベースの基材上で医療試験を実施するため、迅速かつ正確な診断が可能であり、特に遠隔地や資源が限られた地域において有益です。この市場は、使いやすさ、必要最小限の機器、マラリア、HIV、糖尿病などの疾患の検出における有効性などの利点により拡大しています。紙による診断は、製造コストが低く、廃棄が容易で、専門的な人材を必要としないなどの利点があります。環境モニタリング、食品安全試験、臨床診断などに応用されています。特に医療が行き届いていない地域では、即時的で分散化された医療への需要が高まっており、紙診断の普及を後押ししています。技術の進歩に伴い、マイクロ流体工学やセンサーとの統合、スマートフォンとの互換性などがその可能性を高めています。しかし、結果の頑健性と正確性の確保、多様な条件下での安定性の維持、検出可能な分析物の範囲の拡大などの課題も残っています。継続的な調査、製造プロセスの改善、医療プロバイダー、学術機関、業界関係者の協力関係の拡大を通じて、ペーパー診断市場は今後も上昇基調を続けると予想されます。紙ベースのソリューションは、手頃な価格で迅速な診断が可能という世界の目標を達成するための有望な手段となります。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

ペーパー診断の世界市場：製品別

市場概要
ラテラルフローアッセイ
ディップスティック
紙ベースのマイクロ流体工学

ペーパー診断の世界市場：装置タイプ別

市場概要
診断装置
監視装置

ペーパー診断の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Becton, Dickinson and Company（BD）
Siemens Healthineers
bioMerieux
Mologic Ltd.
Diagnostics For All
Micronics
Alere Inc.（Now part of Abbott）
EKF Diagnostics
Nova Biomedical
Zoetis Inc.
Abaxis（Part of Zoetis）
Cytodiagnostics Inc.
Bio-Rad Laboratories, Inc.
ACON Laboratories, Inc.
CellFree Sciences Co., Ltd.

Product Code: SQMIG35H2179

Global Paper Diagnostics Market size was valued at USD 8.35 Billion in 2022 and is poised to grow from USD 9.02 Billion in 2023 to USD Billion 16.69 by 2031, at a CAGR of 8% during the forecast period (2024-2031).

The paper diagnostics market has seen remarkable growth as a portable and cost-effective option for point-of-care testing. These devices conduct medical tests on paper-based substrates, offering swift and precise diagnoses, particularly beneficial in remote or resource-limited areas. The market is expanding due to its advantages, such as ease of use, minimal equipment requirements, and effectiveness in detecting diseases like malaria, HIV, and diabetes. Paper diagnostics offer benefits such as low manufacturing costs, easy disposal, and reduced need for specialized personnel. They find applications in environmental monitoring, food safety testing, and clinical diagnostics. The increasing demand for immediate, decentralized healthcare, especially in underserved regions, has propelled the popularity of paper diagnostics. As technology progresses, integration with microfluidics, sensors, and compatibility with smartphones enhance their potential. Challenges persist, including ensuring the robustness and accuracy of results, maintaining stability under diverse conditions, and broadening the scope of detectable analytes. Through ongoing research, improved manufacturing processes, and growing collaborations between healthcare providers, academic institutions, and industry players, the paper diagnostics market is anticipated to continue its upward trajectory. Paper-based solutions offer a promising avenue to meet the global goal of affordable and rapid diagnostic accessibility.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paper Diagnostics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Paper Diagnostics Market Segmental Analysis

The Paper Diagnostics Market is segmented by product, device type, application, end-use, and region. Based on product the market is segmented as lateral flow assays, dipsticks, and paper based microfluidics. Based on device type the market is segmented as, diagnostic devices, monitoring devices. Based on application the market is segmented as, clinical diagnostics, cancer, infectious diseases, liver disorders, other, food quality testing, and environmental monitoring. Based on end-use the market is segmented as, home healthcare, assisted living healthcare facilities, hospital and clinics, and others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Paper Diagnostics Market

Paper diagnostics facilitate quick and cost-effective point-of-care testing, enabling swift diagnosis and treatment, particularly in resource-limited or rural areas where standard laboratory facilities are lacking.

Paper-based devices are an attractive option due to their relatively low manufacturing costs, which is especially beneficial in regions with limited healthcare budgets or high patient volumes.

Restraints in the Global Paper Diagnostics Market

The entrenched use of traditional diagnostic methods within healthcare systems poses challenges for paper diagnostics to complement or substitute them in certain scenarios.

There may be a need to educate and gain acceptance from healthcare professionals and patients before widespread adoption of paper diagnostics, particularly in regions where these technologies are less familiar.

Market Trends of the Global Paper Diagnostics Market

Emergence of Point-of-Care Testing: The adoption of point-of-care testing was spurred by the demand for fast and convenient diagnostic solutions. The shift towards decentralized healthcare aligned with the ability of paper diagnostics to provide rapid results without specialized equipment.

Technological Progress: The functionalities of paper-based devices were enhanced through the integration of microfluidics, smartphone connectivity, and biosensors. These advancements enabled more sophisticated assays, improved accuracy, and enhanced data transfer.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Paper Diagnostics Market by Product

Market Overview
Lateral Flow Assays
Dipsticks
and Paper Based Microfluidics

Global Paper Diagnostics Market by Device Type

Market Overview
Diagnostic Devices
Monitoring Devices

Global Paper Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mologic Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostics For All
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (Now part of Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abaxis (Part of Zoetis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytodiagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellFree Sciences Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments